Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.3280089983947136e-38,inf,inf,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.063707535087824e-36,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.531157757743115e-20,52.674897119341566,2335.6736635687025,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",8.462671369346966e-18,0,0,40
3,Nonalcoholic fatty liver disease WP4396,7.425177611402211e-14,13.38192419825073,404.55316168585887,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",7.573681163630256e-12,0,0,36
4,Oxidative phosphorylation WP623,1.7108647677408426e-10,27.936507936507937,628.2599916860604,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.3088115473217445e-08,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.8242739757301056e-08,21.37524557956778,356.08265764423703,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",3.5644556731468246e-06,0,0,17
6,Mitochondrial CIV Assembly WP4922,9.197226596007695e-08,37.602739726027394,609.2312698974579,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",4.690585563963924e-06,0,0,15
7,Mitochondrial complex III assembly WP4921,4.940652409445379e-05,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0021597709104146942,0,0,8
8,Amino Acid metabolism WP3925,0.00017144919288144295,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.00582927255796906,0,0,7
9,Glycolysis and Gluconeogenesis WP534,0.00017144919288144295,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.00582927255796906,0,0,7
10,Cellular Proteostasis WP4918,0.02452444356523176,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.6253733109134099,0,0,3
11,Computational Model of Aerobic Glycolysis WP4629,0.02452444356523176,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.6253733109134099,0,0,3
12,Glycolysis in senescence WP5049,0.02452444356523176,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.6253733109134099,0,0,3
13,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03382466770635118,1.7615207373271888,5.965504350527763,"['HSP90AA1', 'SET', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'RPL13A', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V1E1', 'CCT7', 'EIF3D', 'EIF4G2']",0.7654249875305513,0,0,22
14,Selenium Micronutrient Network WP15,0.052864175488495355,2.8683365446371227,8.432993717169168,"['SELENOM', 'GPX4', 'SELENOS', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.7654249875305513,0,0,7
15,Corticotropin-releasing hormone signaling pathway WP2355,0.06318333076969662,4.904214559386973,13.544041765578424,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.7654249875305513,0,0,4
16,Metabolic reprogramming in colon cancer WP4290,0.06318333076969662,4.904214559386973,13.544041765578424,"['LDHA', 'PKM', 'MDH2', 'PGAM1']",0.7654249875305513,0,0,4
17,Nucleotide metabolism WP404,0.07678003545651961,7.347992351816443,18.860904860282805,"['NME2', 'OAZ1', 'SRM']",0.7654249875305513,0,0,3
18,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.07678003545651961,7.347992351816443,18.860904860282805,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.7654249875305513,0,0,3
19,Amyotrophic lateral sclerosis (ALS) WP2447,0.08452539417633391,inf,inf,"['TOMM40', 'BAX']",0.7654249875305513,0,0,2
20,CAMKK2  Pathway WP4874,0.08452539417633391,inf,inf,"['FIS1', 'MAP1LC3A']",0.7654249875305513,0,0,2
21,Type II diabetes mellitus WP1584,0.08452539417633391,inf,inf,"['SURF1', 'PRKCD']",0.7654249875305513,0,0,2
22,Urea cycle and associated pathways WP4595,0.08452539417633391,inf,inf,"['GOT1', 'MDH2']",0.7654249875305513,0,0,2
23,Urea cycle and metabolism of amino groups WP497,0.08452539417633391,inf,inf,"['ODC1', 'SRM']",0.7654249875305513,0,0,2
24,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.08452539417633391,inf,inf,"['TGFB1', 'VIP']",0.7654249875305513,0,0,2
25,Cori Cycle WP1946,0.08452539417633391,inf,inf,"['LDHA', 'PGAM1']",0.7654249875305513,0,0,2
26,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.08452539417633391,inf,inf,"['H3F3B', 'H2AFZ']",0.7654249875305513,0,0,2
27,Gastric acid production WP2596,0.08452539417633391,inf,inf,"['CCK', 'VIP']",0.7654249875305513,0,0,2
28,Glutathione metabolism WP100,0.08452539417633391,inf,inf,"['GPX4', 'GSS']",0.7654249875305513,0,0,2
29,Histone Modifications WP2369,0.08452539417633391,inf,inf,"['SET', 'H3F3B']",0.7654249875305513,0,0,2
30,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.08452539417633391,inf,inf,"['SFRP1', 'TGFB1']",0.7654249875305513,0,0,2
31,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.08452539417633391,inf,inf,"['GOT1', 'MDH2']",0.7654249875305513,0,0,2
32,NO/cGMP/PKG mediated Neuroprotection WP4008,0.08452539417633391,inf,inf,"['PDE3A', 'CYCS']",0.7654249875305513,0,0,2
33,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.08452539417633391,inf,inf,"['TGFB1', 'BAX']",0.7654249875305513,0,0,2
34,Acute viral myocarditis WP4298,0.087548609684867,3.066218809980806,7.467963259571702,"['ENDOG', 'TGFB1', 'CYCS', 'BAX', 'EIF4G2']",0.7654249875305513,0,0,5
35,Proteasome Degradation WP183,0.087548609684867,3.066218809980806,7.467963259571702,"['PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.7654249875305513,0,0,5
36,Ferroptosis WP4313,0.1345283466290622,2.4510556621880997,4.916769486624118,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'FTL']",0.9502794085967164,0,0,5
37,Pathways in clear cell renal cell carcinoma WP4018,0.1345283466290622,2.4510556621880997,4.916769486624118,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.9502794085967164,0,0,5
38,Nanomaterial induced apoptosis WP2507,0.15099233003422488,3.6711281070745696,6.940364009236415,"['ENDOG', 'BAX', 'CYCS']",0.9502794085967164,0,0,3
39,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.15099233003422488,3.6711281070745696,6.940364009236415,"['LDHA', 'PKM', 'BAX']",0.9502794085967164,0,0,3
40,Pregnane X receptor pathway WP2876,0.15099233003422488,3.6711281070745696,6.940364009236415,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9502794085967164,0,0,3
41,Rett syndrome causing genes WP4312,0.15099233003422488,3.6711281070745696,6.940364009236415,"['IMPDH2', 'HAP1', 'GABRD']",0.9502794085967164,0,0,3
42,Modulators of TCR signaling and T cell activation WP5072,0.17749818148801202,2.4482758620689653,4.2325668614915415,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9502794085967164,0,0,4
43,DNA Repair Pathways Full Network WP4946,0.19633318400970484,1.8375,2.991343690630331,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'APEX1']",0.9502794085967164,0,0,6
44,ACE Inhibitor Pathway WP554,0.20452729872274128,4.8893129770992365,7.759602848831626,"['TGFB1', 'ATP6AP2']",0.9502794085967164,0,0,2
45,Type II interferon signaling (IFNG) WP619,0.20452729872274128,4.8893129770992365,7.759602848831626,"['PRKCD', 'HLA-B']",0.9502794085967164,0,0,2
46,Cysteine and methionine catabolism WP4504,0.20452729872274128,4.8893129770992365,7.759602848831626,"['GOT1', 'GSS']",0.9502794085967164,0,0,2
47,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.20452729872274128,4.8893129770992365,7.759602848831626,"['MAPK11', 'BAX']",0.9502794085967164,0,0,2
48,Neovascularisation processes WP4331,0.20452729872274128,4.8893129770992365,7.759602848831626,"['TGFB1', 'KIT']",0.9502794085967164,0,0,2
49,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.20452729872274128,4.8893129770992365,7.759602848831626,"['MAP1LC3A', 'FTL']",0.9502794085967164,0,0,2
50,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.20452729872274128,4.8893129770992365,7.759602848831626,"['EIF3I', 'EIF3D']",0.9502794085967164,0,0,2
51,Oxidation by Cytochrome P450 WP43,0.20452729872274128,4.8893129770992365,7.759602848831626,"['CYB5R1', 'CYP3A5']",0.9502794085967164,0,0,2
52,16p11.2 proximal deletion syndrome WP4949,0.23880133496839612,2.445506692160612,3.502267131657498,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9502794085967164,0,0,3
53,Base Excision Repair WP4752,0.23880133496839612,2.445506692160612,3.502267131657498,"['POLE4', 'NEIL2', 'APEX1']",0.9502794085967164,0,0,3
54,Differentiation Pathway WP2848,0.23880133496839612,2.445506692160612,3.502267131657498,"['TGFB1', 'KIT', 'FGF1']",0.9502794085967164,0,0,3
55,DNA IR-double strand breaks and cellular response via ATM WP3959,0.23880133496839612,2.445506692160612,3.502267131657498,"['DCLRE1C', 'KAT5', 'BAX']",0.9502794085967164,0,0,3
56,GABA receptor Signaling WP4159,0.23880133496839612,2.445506692160612,3.502267131657498,"['GABBR1', 'SLC32A1', 'GABRD']",0.9502794085967164,0,0,3
57,Aryl Hydrocarbon Receptor Pathway WP2873,0.24945784046113212,1.957088122605364,2.7173490533075286,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9502794085967164,0,0,4
58,Pyrimidine metabolism WP4022,0.25141804628772857,1.632051282051282,2.253272348010018,"['POLE4', 'NME2', 'NME3', 'POLR2I', 'POLR2K', 'POLR2L']",0.9502794085967164,0,0,6
59,Gastrin signaling pathway WP4659,0.25219167880358706,1.7480120647107211,2.4080017264856024,"['KAT5', 'RPS6', 'PRKCD', 'KIT', 'PRKD1']",0.9502794085967164,0,0,5
60,Hepatitis B infection WP4666,0.25219167880358706,1.7480120647107211,2.4080017264856024,"['MAPK11', 'TGFB1', 'ATP6AP1', 'CYCS', 'BAX']",0.9502794085967164,0,0,5
61,15q11.2 copy number variation syndrome WP4940,0.29092899204810124,inf,inf,['TUBGCP4'],0.9502794085967164,0,0,1
62,Selective expression of chemokine receptors during T-cell polarization WP4494,0.29092899204810124,inf,inf,['TGFB1'],0.9502794085967164,0,0,1
63,16p11.2 distal deletion syndrome WP4950,0.29092899204810124,inf,inf,['CD81'],0.9502794085967164,0,0,1
64,Tamoxifen metabolism WP691,0.29092899204810124,inf,inf,['CYP3A5'],0.9502794085967164,0,0,1
65,TCA cycle in senescence WP5050,0.29092899204810124,inf,inf,['GOT1'],0.9502794085967164,0,0,1
66,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.29092899204810124,inf,inf,['TGFB1'],0.9502794085967164,0,0,1
67,Biomarkers for urea cycle disorders WP4583,0.29092899204810124,inf,inf,['GOT1'],0.9502794085967164,0,0,1
68,Thiamine metabolic pathways WP4297,0.29092899204810124,inf,inf,['BCKDK'],0.9502794085967164,0,0,1
69,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.29092899204810124,inf,inf,['RPS6'],0.9502794085967164,0,0,1
70,Canonical and non-canonical TGF-B signaling WP3874,0.29092899204810124,inf,inf,['TGFB1'],0.9502794085967164,0,0,1
71,"Cerebral organic acidurias, including diseases WP4519",0.29092899204810124,inf,inf,['MDH2'],0.9502794085967164,0,0,1
72,Ebstein-Barr virus LMP1 signaling WP262,0.29092899204810124,inf,inf,['HSP90AA1'],0.9502794085967164,0,0,1
73,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.29092899204810124,inf,inf,['H3F3B'],0.9502794085967164,0,0,1
74,EV release from cardiac cells and their functional effects WP3297,0.29092899204810124,inf,inf,['RGS16'],0.9502794085967164,0,0,1
75,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.29092899204810124,inf,inf,['GSS'],0.9502794085967164,0,0,1
76,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.29092899204810124,inf,inf,['GABBR1'],0.9502794085967164,0,0,1
77,HIF1A and PPARG regulation of glycolysis WP2456,0.29092899204810124,inf,inf,['LDHA'],0.9502794085967164,0,0,1
78,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.29092899204810124,inf,inf,['ELOB'],0.9502794085967164,0,0,1
79,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.29092899204810124,inf,inf,['MAP1LC3A'],0.9502794085967164,0,0,1
80,Insulin signaling in adipocytes (diabetic condition) WP3635,0.29092899204810124,inf,inf,['RPS6'],0.9502794085967164,0,0,1
81,Insulin signaling in adipocytes (normal condition) WP3634,0.29092899204810124,inf,inf,['RPS6'],0.9502794085967164,0,0,1
82,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.29092899204810124,inf,inf,['TGFB1'],0.9502794085967164,0,0,1
83,Irinotecan pathway WP229,0.29092899204810124,inf,inf,['CYP3A5'],0.9502794085967164,0,0,1
84,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.29092899204810124,inf,inf,['GABRD'],0.9502794085967164,0,0,1
85,Mitochondrial fatty acid synthesis pathway WP4317,0.29092899204810124,inf,inf,['HSD17B12'],0.9502794085967164,0,0,1
86,Nanoparticle triggered autophagic cell death WP2509,0.29092899204810124,inf,inf,['MAP1LC3A'],0.9502794085967164,0,0,1
87,Nanoparticle triggered regulated necrosis WP2513,0.29092899204810124,inf,inf,['FTL'],0.9502794085967164,0,0,1
88,Non-homologous end joining WP438,0.29092899204810124,inf,inf,['DCLRE1C'],0.9502794085967164,0,0,1
89,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.29092899204810124,inf,inf,['MAPK11'],0.9502794085967164,0,0,1
90,Peroxiredoxin 2 induced ovarian failure WP4873,0.29092899204810124,inf,inf,['BAX'],0.9502794085967164,0,0,1
91,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.29092899204810124,inf,inf,['LDHA'],0.9502794085967164,0,0,1
92,Platelet-mediated interactions with vascular and circulating cells WP4462,0.29092899204810124,inf,inf,['TGFB1'],0.9502794085967164,0,0,1
93,Ciliary landscape WP4352,0.30193368901322815,1.4274245343609506,1.709409194323985,"['VPS4A', 'CD2BP2', 'COPS7A', 'MYL6B', 'COX6C', 'DCAF11', 'LSM4']",0.9502794085967164,0,0,7
94,IL-18 signaling pathway WP4754,0.31300299882209165,1.2825705039297273,1.4897601592911818,"['TOMM40', 'USP5', 'CD81', 'TMSB4X', 'RGS16', 'SYT10', 'PRKCD', 'COX17', 'CYCS', 'BAX', 'NDUFC1']",0.9502794085967164,0,0,11
95,Apoptosis Modulation and Signaling WP1772,0.3182691275050634,1.5283109404990403,1.7496989168742545,"['HRK', 'ENDOG', 'CYCS', 'BAX', 'PRKD1']",0.9502794085967164,0,0,5
96,mRNA Processing WP411,0.3182691275050634,1.5283109404990403,1.7496989168742545,"['SF3B5', 'LSM7', 'SF3A1', 'CD2BP2', 'SRSF9']",0.9502794085967164,0,0,5
97,Endoderm differentiation WP2853,0.32607748992772295,1.6296296296296295,1.826195924987061,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2']",0.9502794085967164,0,0,4
98,Proximal tubule transport WP4917,0.32607748992772295,1.6296296296296295,1.826195924987061,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9502794085967164,0,0,4
99,Cardiac Hypertrophic Response WP2795,0.3322745241597757,2.4427480916030535,2.691404633265962,"['TGFB1', 'PRKD1']",0.9502794085967164,0,0,2
100,Type 2 papillary renal cell carcinoma WP4241,0.3322745241597757,2.4427480916030535,2.691404633265962,"['TGFB1', 'ELOB']",0.9502794085967164,0,0,2
101,Constitutive Androstane Receptor Pathway WP2875,0.3322745241597757,2.4427480916030535,2.691404633265962,"['HSP90AA1', 'CYP3A5']",0.9502794085967164,0,0,2
102,Cytosolic DNA-sensing pathway WP4655,0.3322745241597757,2.4427480916030535,2.691404633265962,"['POLR2K', 'POLR2L']",0.9502794085967164,0,0,2
103,Methionine De Novo and Salvage Pathway WP3580,0.3322745241597757,2.4427480916030535,2.691404633265962,"['ODC1', 'SRM']",0.9502794085967164,0,0,2
104,Synaptic Vesicle Pathway WP2267,0.33228724418251193,1.8326959847036328,2.019182864130519,"['SLC32A1', 'PARK7', 'CPLX3']",0.9502794085967164,0,0,3
105,Translation Factors WP107,0.33228724418251193,1.8326959847036328,2.019182864130519,"['EEF1B2', 'EIF3I', 'EIF3D']",0.9502794085967164,0,0,3
106,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.33228724418251193,1.8326959847036328,2.019182864130519,"['MAPK11', 'HSP90AA1', 'BAX']",0.9502794085967164,0,0,3
107,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.33228724418251193,1.8326959847036328,2.019182864130519,"['MAPK11', 'BAX', 'ANGPTL1']",0.9502794085967164,0,0,3
108,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.42516064622460675,1.4650095602294455,1.2530053756311497,"['TGFB1', 'CYCS', 'BAX']",0.9873061158363836,0,0,3
109,Eukaryotic Transcription Initiation WP405,0.42516064622460675,1.4650095602294455,1.2530053756311497,"['TAF13', 'POLR2I', 'POLR2K']",0.9873061158363836,0,0,3
110,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.42516064622460675,1.4650095602294455,1.2530053756311497,"['IFI27L2', 'MAPK11', 'PRKCD']",0.9873061158363836,0,0,3
111,Parkinson's disease pathway WP2371,0.42516064622460675,1.4650095602294455,1.2530053756311497,"['MAPK11', 'CYCS', 'PARK7']",0.9873061158363836,0,0,3
112,MAPK Signaling Pathway WP382,0.4315435163545637,1.2211538461538463,1.026241725132479,"['DUSP4', 'MAPK11', 'TGFB1', 'DDIT3', 'PRKCD', 'FGF1']",0.9873061158363836,0,0,6
113,AGE/RAGE pathway WP2324,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['PRKCD', 'CYCS']",0.9873061158363836,0,0,2
114,ATM Signaling Network in Development and Disease  WP3878,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['DCLRE1C', 'KAT5']",0.9873061158363836,0,0,2
115,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['SFRP1', 'SST']",0.9873061158363836,0,0,2
116,TNF-alpha signaling pathway WP231,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['HSP90AA1', 'BAX']",0.9873061158363836,0,0,2
117,TP53 network WP1742,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['SUMO1', 'BAX']",0.9873061158363836,0,0,2
118,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['PRKCD', 'RPS6']",0.9873061158363836,0,0,2
119,Complement system WP2806,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['RPS19', 'CD59']",0.9873061158363836,0,0,2
120,Copper homeostasis WP3286,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['COX17', 'ATOX1']",0.9873061158363836,0,0,2
121,Glycosylation and related congenital defects WP4521,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['DPM2', 'DPM3']",0.9873061158363836,0,0,2
122,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['LDHA', 'RPS6']",0.9873061158363836,0,0,2
123,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['MAPK11', 'DDIT3']",0.9873061158363836,0,0,2
124,Interleukin-11 Signaling Pathway WP2332,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['TGFB1', 'RPS6']",0.9873061158363836,0,0,2
125,Kit receptor signaling pathway WP304,0.45312925954223976,1.6272264631043256,1.2880764300875012,"['RPS6', 'KIT']",0.9873061158363836,0,0,2
126,Spinal Cord Injury WP2431,0.47953872918311635,1.2203065134099618,0.8968406200337653,"['TGFB1', 'APEX1', 'CCNG1', 'OMG']",0.9873061158363836,0,0,4
127,Serotonin and anxiety WP3947,0.49733236675867826,2.44,1.7043320221836888,['CRH'],0.9873061158363836,0,0,1
128,Serotonin and anxiety-related events WP3944,0.49733236675867826,2.44,1.7043320221836888,['CRH'],0.9873061158363836,0,0,1
129,Apoptosis Modulation by HSP70 WP384,0.49733236675867826,2.44,1.7043320221836888,['CYCS'],0.9873061158363836,0,0,1
130,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.49733236675867826,2.44,1.7043320221836888,['MAPK11'],0.9873061158363836,0,0,1
131,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.49733236675867826,2.44,1.7043320221836888,['MDH2'],0.9873061158363836,0,0,1
132,Trans-sulfuration and one-carbon metabolism WP2525,0.49733236675867826,2.44,1.7043320221836888,['GSS'],0.9873061158363836,0,0,1
133,Trans-sulfuration pathway WP2333,0.49733236675867826,2.44,1.7043320221836888,['GOT1'],0.9873061158363836,0,0,1
134,Transcriptional cascade regulating adipogenesis WP4211,0.49733236675867826,2.44,1.7043320221836888,['DDIT3'],0.9873061158363836,0,0,1
135,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.49733236675867826,2.44,1.7043320221836888,['CCK'],0.9873061158363836,0,0,1
136,Cytokines and Inflammatory Response WP530,0.49733236675867826,2.44,1.7043320221836888,['TGFB1'],0.9873061158363836,0,0,1
137,Dopaminergic Neurogenesis WP2855,0.49733236675867826,2.44,1.7043320221836888,['TGFB1'],0.9873061158363836,0,0,1
138,Dual hijack model of Vif in HIV infection WP3300,0.49733236675867826,2.44,1.7043320221836888,['ELOB'],0.9873061158363836,0,0,1
139,Gastric Cancer Network 2 WP2363,0.49733236675867826,2.44,1.7043320221836888,['FANCI'],0.9873061158363836,0,0,1
140,Heart Development WP1591,0.49733236675867826,2.44,1.7043320221836888,['VEGFB'],0.9873061158363836,0,0,1
141,Interferon type I signaling pathways WP585,0.49733236675867826,2.44,1.7043320221836888,['RPS6'],0.9873061158363836,0,0,1
142,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.49733236675867826,2.44,1.7043320221836888,['BAX'],0.9873061158363836,0,0,1
143,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.49733236675867826,2.44,1.7043320221836888,['VEGFB'],0.9873061158363836,0,0,1
144,miRNA regulation of p53 pathway in prostate cancer WP3982,0.49733236675867826,2.44,1.7043320221836888,['BAX'],0.9873061158363836,0,0,1
145,MTHFR deficiency WP4288,0.49733236675867826,2.44,1.7043320221836888,['CYCS'],0.9873061158363836,0,0,1
146,Neural Crest Cell Migration during Development WP4564,0.49733236675867826,2.44,1.7043320221836888,['EPHB3'],0.9873061158363836,0,0,1
147,Neural Crest Cell Migration in Cancer WP4565,0.49733236675867826,2.44,1.7043320221836888,['EPHB3'],0.9873061158363836,0,0,1
148,Osteoclast Signaling WP12,0.49733236675867826,2.44,1.7043320221836888,['ATP6V1G1'],0.9873061158363836,0,0,1
149,Overview of nanoparticle effects WP3287,0.49733236675867826,2.44,1.7043320221836888,['BAX'],0.9873061158363836,0,0,1
150,PKC-gamma calcium signaling pathway in ataxia WP4760,0.49733236675867826,2.44,1.7043320221836888,['TRPC3'],0.9873061158363836,0,0,1
151,Purinergic signaling WP4900,0.49733236675867826,2.44,1.7043320221836888,['P2RY14'],0.9873061158363836,0,0,1
152,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.49733236675867826,2.44,1.7043320221836888,['ANAPC11'],0.9873061158363836,0,0,1
153,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.49733236675867826,2.44,1.7043320221836888,['TGFB1'],0.9873061158363836,0,0,1
154,SARS-CoV-2 mitochondrial interactions WP5038,0.49733236675867826,2.44,1.7043320221836888,['NDUFB9'],0.9873061158363836,0,0,1
155,Allograft Rejection WP2328,0.513012001365964,1.219885277246654,0.8142197959289282,"['TGFB1', 'COL5A1', 'HLA-B']",0.9873061158363836,0,0,3
156,Apoptosis WP254,0.513012001365964,1.219885277246654,0.8142197959289282,"['HRK', 'CYCS', 'BAX']",0.9873061158363836,0,0,3
157,Exercise-induced Circadian Regulation WP410,0.513012001365964,1.219885277246654,0.8142197959289282,"['DAZAP2', 'SUMO1', 'EIF4G2']",0.9873061158363836,0,0,3
158,miRNA regulation of DNA damage response WP1530,0.513012001365964,1.219885277246654,0.8142197959289282,"['CCNG1', 'CYCS', 'BAX']",0.9873061158363836,0,0,3
159,Pancreatic adenocarcinoma pathway WP4263,0.513012001365964,1.219885277246654,0.8142197959289282,"['TGFB1', 'PRKCD', 'BAX']",0.9873061158363836,0,0,3
160,Osteoblast differentiation WP4787,0.5512140654320559,1.0838654746700724,0.6455850056825213,"['MAPK11', 'PRKCD', 'PRKD1', 'FGF1']",0.9881928752917253,0,0,4
161,Alzheimer's disease WP2059,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['ATP5MD', 'CYCS']",0.9881928752917253,0,0,2
162,Genotoxicity pathway WP4286,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['RPS27', 'PHLDA3']",0.9881928752917253,0,0,2
163,IL-6 signaling pathway WP364,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['PRKCD', 'VIP']",0.9881928752917253,0,0,2
164,Lung fibrosis WP3624,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['TGFB1', 'FGF1']",0.9881928752917253,0,0,2
165,One-carbon metabolism and related pathways WP3940,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['GPX4', 'GSS']",0.9881928752917253,0,0,2
166,p53 transcriptional gene network WP4963,0.5602931482263762,1.2194656488549618,0.7064305399299505,"['CCNG1', 'BAX']",0.9881928752917253,0,0,2
167,7q11.23 copy number variation syndrome WP4932,0.5931267354854122,1.044796503687517,0.5457465111565948,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9881928752917253,0,0,3
168,Metapathway biotransformation Phase I and II WP702,0.5931267354854122,1.044796503687517,0.5457465111565948,"['GPX4', 'GSS', 'CYP3A5']",0.9881928752917253,0,0,3
169,Androgen receptor signaling pathway WP138,0.6172951235222793,0.9747126436781609,0.47020922506678203,"['SUMO1', 'KAT5', 'STUB1', 'PARK7']",0.9881928752917253,0,0,4
170,Signal transduction through IL1R WP4496,0.6437347393807429,1.2190476190476192,0.5369521165427812,['TGFB1'],0.9881928752917253,0,0,1
171,Alanine and aspartate metabolism WP106,0.6437347393807429,1.2190476190476192,0.5369521165427812,['GOT1'],0.9881928752917253,0,0,1
172,Alpha 6 Beta 4 signaling pathway WP244,0.6437347393807429,1.2190476190476192,0.5369521165427812,['PRKCD'],0.9881928752917253,0,0,1
173,BMP Signaling Pathway in Eyelid Development WP3927,0.6437347393807429,1.2190476190476192,0.5369521165427812,['SFRP1'],0.9881928752917253,0,0,1
174,Cannabinoid receptor signaling WP3869,0.6437347393807429,1.2190476190476192,0.5369521165427812,['MAPK11'],0.9881928752917253,0,0,1
175,Cell migration and invasion through p75NTR WP4561,0.6437347393807429,1.2190476190476192,0.5369521165427812,['EFNB3'],0.9881928752917253,0,0,1
176,Vitamin D-sensitive calcium signaling in depression WP4698,0.6437347393807429,1.2190476190476192,0.5369521165427812,['GPX4'],0.9881928752917253,0,0,1
177,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6437347393807429,1.2190476190476192,0.5369521165427812,['RPS6'],0.9881928752917253,0,0,1
178,Galanin receptor pathway WP4970,0.6437347393807429,1.2190476190476192,0.5369521165427812,['PRKCD'],0.9881928752917253,0,0,1
179,Genes targeted by miRNAs in adipocytes WP1992,0.6437347393807429,1.2190476190476192,0.5369521165427812,['TMSB4X'],0.9881928752917253,0,0,1
180,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6437347393807429,1.2190476190476192,0.5369521165427812,['FGF1'],0.9881928752917253,0,0,1
181,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6437347393807429,1.2190476190476192,0.5369521165427812,['TGFB1'],0.9881928752917253,0,0,1
182,IL-5 signaling pathway WP127,0.6437347393807429,1.2190476190476192,0.5369521165427812,['RPS6'],0.9881928752917253,0,0,1
183,Joubert Syndrome WP4656,0.6437347393807429,1.2190476190476192,0.5369521165427812,['KAT5'],0.9881928752917253,0,0,1
184,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6437347393807429,1.2190476190476192,0.5369521165427812,['PRKCD'],0.9881928752917253,0,0,1
185,Matrix Metalloproteinases WP129,0.6437347393807429,1.2190476190476192,0.5369521165427812,['MMP16'],0.9881928752917253,0,0,1
186,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6437347393807429,1.2190476190476192,0.5369521165427812,['B3GALT2'],0.9881928752917253,0,0,1
187,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6437347393807429,1.2190476190476192,0.5369521165427812,['MAPK11'],0.9881928752917253,0,0,1
188,Pre-implantation embryo WP3527,0.6437347393807429,1.2190476190476192,0.5369521165427812,['DDIT3'],0.9881928752917253,0,0,1
189,Prolactin Signaling Pathway WP2037,0.6437347393807429,1.2190476190476192,0.5369521165427812,['RPS6'],0.9881928752917253,0,0,1
190,Aryl Hydrocarbon Receptor Netpath WP2586,0.6514954283259063,0.9748091603053435,0.4176910051759578,"['HSP90AA1', 'AIP']",0.9881928752917253,0,0,2
191,Thermogenesis WP4321,0.6514954283259063,0.9748091603053435,0.4176910051759578,"['MAPK11', 'RPS6']",0.9881928752917253,0,0,2
192,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6514954283259063,0.9748091603053435,0.4176910051759578,"['APEX1', 'RPS6']",0.9881928752917253,0,0,2
193,Leptin signaling pathway WP2034,0.6514954283259063,0.9748091603053435,0.4176910051759578,"['RPS6', 'BAX']",0.9881928752917253,0,0,2
194,Regulation of toll-like receptor signaling pathway WP1449,0.6514954283259063,0.9748091603053435,0.4176910051759578,"['MAPK11', 'PELI3']",0.9881928752917253,0,0,2
195,TGF-beta Signaling Pathway WP366,0.6641405476244516,0.9134799235181644,0.3738521489160993,"['TGFB1', 'PARD6A', 'SUMO1']",0.9881928752917253,0,0,3
196,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6641405476244516,0.9134799235181644,0.3738521489160993,"['RPS6', 'PDGFC', 'BAX']",0.9881928752917253,0,0,3
197,Calcium Regulation in the Cardiac Cell WP536,0.6769267883487807,0.8854057819575061,0.34547838852165563,"['RGS16', 'PRKCD', 'ATP1B2', 'PRKD1']",0.9881928752917253,0,0,4
198,Myometrial relaxation and contraction pathways WP289,0.6769267883487807,0.8854057819575061,0.34547838852165563,"['RGS16', 'PRKCD', 'CRH', 'PRKD1']",0.9881928752917253,0,0,4
199,22q11.2 copy number variation syndrome WP4657,0.726940269104074,0.811704834605598,0.2588615725994057,"['RANBP1', 'MRPL40']",0.9881928752917253,0,0,2
200,B Cell Receptor Signaling Pathway WP23,0.726940269104074,0.811704834605598,0.2588615725994057,"['CD81', 'PRKCD']",0.9881928752917253,0,0,2
201,Cardiac Progenitor Differentiation WP2406,0.726940269104074,0.811704834605598,0.2588615725994057,"['TGFB1', 'KIT']",0.9881928752917253,0,0,2
202,DNA damage response WP707,0.726940269104074,0.811704834605598,0.2588615725994057,"['CYCS', 'BAX']",0.9881928752917253,0,0,2
203,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.726940269104074,0.811704834605598,0.2588615725994057,"['MAP1LC3A', 'DDIT3']",0.9881928752917253,0,0,2
204,MECP2 and Associated Rett Syndrome WP3584,0.726940269104074,0.811704834605598,0.2588615725994057,"['SST', 'RPS6']",0.9881928752917253,0,0,2
205,Non-small cell lung cancer WP4255,0.726940269104074,0.811704834605598,0.2588615725994057,"['CYCS', 'BAX']",0.9881928752917253,0,0,2
206,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7475546708103891,0.812063492063492,0.2362681174839299,['TGFB1'],0.9881928752917253,0,0,1
207,Sleep regulation WP3591,0.7475546708103891,0.812063492063492,0.2362681174839299,['CRH'],0.9881928752917253,0,0,1
208,Target Of Rapamycin (TOR) Signaling WP1471,0.7475546708103891,0.812063492063492,0.2362681174839299,['RRAGA'],0.9881928752917253,0,0,1
209,BDNF-TrkB Signaling WP3676,0.7475546708103891,0.812063492063492,0.2362681174839299,['TRPC3'],0.9881928752917253,0,0,1
210,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7475546708103891,0.812063492063492,0.2362681174839299,['TGFB1'],0.9881928752917253,0,0,1
211,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7475546708103891,0.812063492063492,0.2362681174839299,['RPS6'],0.9881928752917253,0,0,1
212,Toll-like Receptor Signaling Pathway WP75,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
213,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7475546708103891,0.812063492063492,0.2362681174839299,['TGFB1'],0.9881928752917253,0,0,1
214,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.7475546708103891,0.812063492063492,0.2362681174839299,['CD81'],0.9881928752917253,0,0,1
215,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
216,IL-2 signaling pathway WP49,0.7475546708103891,0.812063492063492,0.2362681174839299,['RPS6'],0.9881928752917253,0,0,1
217,IL-3 signaling pathway WP286,0.7475546708103891,0.812063492063492,0.2362681174839299,['TGFB1'],0.9881928752917253,0,0,1
218,IL-4 signaling pathway WP395,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
219,Integrated Cancer Pathway WP1971,0.7475546708103891,0.812063492063492,0.2362681174839299,['BAX'],0.9881928752917253,0,0,1
220,Mammalian disorder of sexual development WP4842,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
221,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
222,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7475546708103891,0.812063492063492,0.2362681174839299,['COL5A1'],0.9881928752917253,0,0,1
223,Nanoparticle-mediated activation of receptor signaling WP2643,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
224,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7475546708103891,0.812063492063492,0.2362681174839299,['OMG'],0.9881928752917253,0,0,1
225,Ovarian infertility WP34,0.7475546708103891,0.812063492063492,0.2362681174839299,['INHA'],0.9881928752917253,0,0,1
226,Oxidative Damage WP3941,0.7475546708103891,0.812063492063492,0.2362681174839299,['CYCS'],0.9881928752917253,0,0,1
227,Physiological and pathological hypertrophy of the heart WP1528,0.7475546708103891,0.812063492063492,0.2362681174839299,['MAPK11'],0.9881928752917253,0,0,1
228,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7475546708103891,0.812063492063492,0.2362681174839299,['BAX'],0.9881928752917253,0,0,1
229,Regulation of Microtubule Cytoskeleton WP2038,0.7475546708103891,0.812063492063492,0.2362681174839299,['PARD6A'],0.9881928752917253,0,0,1
230,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7568514455908724,0.8095238095238095,0.22552385038171352,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1']",0.9881928752917253,0,0,8
231,EGF/EGFR signaling pathway WP437,0.7780124553673465,0.7296367112810708,0.18314811408874404,"['NDUFA13', 'PRKCD', 'NEDD8']",0.9881928752917253,0,0,3
232,Small cell lung cancer WP4658,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['CYCS', 'BAX']",0.9881928752917253,0,0,2
233,T-cell receptor (TCR) signaling pathway WP69,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['TGFB1', 'PRKCD']",0.9881928752917253,0,0,2
234,Wnt signaling pathway and pluripotency WP399,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['PRKCD', 'PRKD1']",0.9881928752917253,0,0,2
235,Endometrial cancer WP4155,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['BAX', 'FGF1']",0.9881928752917253,0,0,2
236,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['MAPK11', 'TGFB1']",0.9881928752917253,0,0,2
237,G Protein Signaling Pathways WP35,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['PRKCD', 'PRKD1']",0.9881928752917253,0,0,2
238,Melanoma WP4685,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['KIT', 'BAX']",0.9881928752917253,0,0,2
239,Pathways Regulating Hippo Signaling WP4540,0.7880625416681173,0.6952017448200655,0.16558163929120562,"['PRKCD', 'KIT']",0.9881928752917253,0,0,2
240,3q29 copy number variation syndrome WP4906,0.8211608906917685,0.6085714285714285,0.11991061361506022,['TGFB1'],0.9881928752917253,0,0,1
241,Tumor suppressor activity of SMARCB1 WP4204,0.8211608906917685,0.6085714285714285,0.11991061361506022,['H3F3B'],0.9881928752917253,0,0,1
242,Zinc homeostasis WP3529,0.8211608906917685,0.6085714285714285,0.11991061361506022,['SLC39A7'],0.9881928752917253,0,0,1
243,DNA Mismatch Repair WP531,0.8211608906917685,0.6085714285714285,0.11991061361506022,['POLE4'],0.9881928752917253,0,0,1
244,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8211608906917685,0.6085714285714285,0.11991061361506022,['TGFB1'],0.9881928752917253,0,0,1
245,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8211608906917685,0.6085714285714285,0.11991061361506022,['MAP1LC3A'],0.9881928752917253,0,0,1
246,Folate Metabolism WP176,0.8211608906917685,0.6085714285714285,0.11991061361506022,['GPX4'],0.9881928752917253,0,0,1
247,Glycogen Synthesis and Degradation WP500,0.8211608906917685,0.6085714285714285,0.11991061361506022,['PHKG1'],0.9881928752917253,0,0,1
248,Mesodermal commitment pathway WP2857,0.8211608906917685,0.6085714285714285,0.11991061361506022,['RPL38'],0.9881928752917253,0,0,1
249,miRNA targets in ECM and membrane receptors WP2911,0.8211608906917685,0.6085714285714285,0.11991061361506022,['COL5A1'],0.9881928752917253,0,0,1
250,p38 MAPK Signaling Pathway WP400,0.8211608906917685,0.6085714285714285,0.11991061361506022,['DDIT3'],0.9881928752917253,0,0,1
251,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8211608906917685,0.6085714285714285,0.11991061361506022,['MAPK11'],0.9881928752917253,0,0,1
252,NRF2 pathway WP2884,0.8492152735376358,0.6472541507024265,0.10578887763922391,"['HSP90AA1', 'TGFB1', 'SLC39A7', 'FTL']",0.9881928752917253,0,0,4
253,Breast cancer pathway WP4262,0.8580737075651584,0.607074569789675,0.09292203714250725,"['KIT', 'BAX', 'FGF1']",0.9881928752917253,0,0,3
254,Integrated breast cancer pathway WP1984,0.8580737075651584,0.607074569789675,0.09292203714250725,"['ODC1', 'BAX', 'FAU']",0.9881928752917253,0,0,3
255,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8733343104148695,0.48647619047619045,0.06588680385973314,['TMSB4X'],0.9881928752917253,0,0,1
256,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8733343104148695,0.48647619047619045,0.06588680385973314,['TGFB1'],0.9881928752917253,0,0,1
257,TGF-beta Receptor Signaling WP560,0.8733343104148695,0.48647619047619045,0.06588680385973314,['TGFB1'],0.9881928752917253,0,0,1
258,Chemokine signaling pathway WP3929,0.8733343104148695,0.48647619047619045,0.06588680385973314,['PRKCD'],0.9881928752917253,0,0,1
259,Unfolded protein response WP4925,0.8733343104148695,0.48647619047619045,0.06588680385973314,['DDIT3'],0.9881928752917253,0,0,1
260,White fat cell differentiation WP4149,0.8733343104148695,0.48647619047619045,0.06588680385973314,['DDIT3'],0.9881928752917253,0,0,1
261,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8733343104148695,0.48647619047619045,0.06588680385973314,['CYCS'],0.9881928752917253,0,0,1
262,Imatinib and Chronic Myeloid Leukemia WP3640,0.8733343104148695,0.48647619047619045,0.06588680385973314,['KIT'],0.9881928752917253,0,0,1
263,MET in type 1 papillary renal cell carcinoma WP4205,0.8733343104148695,0.48647619047619045,0.06588680385973314,['RPL11'],0.9881928752917253,0,0,1
264,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8733343104148695,0.48647619047619045,0.06588680385973314,['TGFB1'],0.9881928752917253,0,0,1
265,Nucleotide Excision Repair WP4753,0.8733343104148695,0.48647619047619045,0.06588680385973314,['POLE4'],0.9881928752917253,0,0,1
266,Phosphodiesterases in neuronal function WP4222,0.8733343104148695,0.48647619047619045,0.06588680385973314,['PDE3A'],0.9881928752917253,0,0,1
267,Prader-Willi and Angelman Syndrome WP3998,0.8733343104148695,0.48647619047619045,0.06588680385973314,['GABRD'],0.9881928752917253,0,0,1
268,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8751642784446325,0.5398642917726887,0.07198748243236511,"['BEX3', 'RNF7']",0.9881928752917253,0,0,2
269,DNA damage response (only ATM dependent) WP710,0.8751642784446325,0.5398642917726887,0.07198748243236511,"['TGFB1', 'BAX']",0.9881928752917253,0,0,2
270,Ebola Virus Pathway on Host WP4217,0.8751642784446325,0.5398642917726887,0.07198748243236511,"['VPS4A', 'HLA-B']",0.9881928752917253,0,0,2
271,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8751642784446325,0.5398642917726887,0.07198748243236511,"['PSMC5', 'STUB1']",0.9881928752917253,0,0,2
272,Vitamin D Receptor Pathway WP2877,0.8876832237039527,0.5599352846006765,0.06671087441596567,"['SFRP1', 'TGFB1', 'CYP3A5']",0.989233457111061,0,0,3
273,Insulin Signaling WP481,0.8876832237039527,0.5599352846006765,0.06671087441596567,"['MAPK11', 'PRKCD', 'PFKM']",0.989233457111061,0,0,3
274,Nuclear Receptors Meta-Pathway WP2882,0.9038018390093162,0.6445302445302445,0.06519110649300364,"['PSMC5', 'HSP90AA1', 'TGFB1', 'AIP', 'BAX', 'SLC39A7', 'CYP3A5', 'FTL']",0.989233457111061,0,0,8
275,Oncostatin M Signaling Pathway WP2374,0.9050621600704747,0.4854961832061069,0.04842904654763087,"['PRKCD', 'RPS6']",0.989233457111061,0,0,2
276,PI3K-Akt signaling pathway WP4172,0.9089626835071947,0.6048076923076923,0.05772964291896697,"['HSP90AA1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1']",0.989233457111061,0,0,6
277,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9103073327819284,0.4050793650793651,0.038066526478765746,['TGFB1'],0.989233457111061,0,0,1
278,DNA IR-damage and cellular response via ATR WP4016,0.9103073327819284,0.4050793650793651,0.038066526478765746,['FANCI'],0.989233457111061,0,0,1
279,Fragile X Syndrome  WP4549,0.9103073327819284,0.4050793650793651,0.038066526478765746,['GABRD'],0.989233457111061,0,0,1
280,Glucocorticoid Receptor Pathway WP2880,0.9103073327819284,0.4050793650793651,0.038066526478765746,['HSP90AA1'],0.989233457111061,0,0,1
281,Photodynamic therapy-induced unfolded protein response WP3613,0.9103073327819284,0.4050793650793651,0.038066526478765746,['DDIT3'],0.989233457111061,0,0,1
282,Adipogenesis WP236,0.9116465192984289,0.5195301830101066,0.04805807585595242,"['WWTR1', 'TGFB1', 'DDIT3']",0.989233457111061,0,0,3
283,Senescence and Autophagy in Cancer WP615,0.9206803094779048,0.5381013197105151,0.04446999278333846,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'GABARAP']",0.9930684531677161,0,0,4
284,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9281620183201529,0.44101318528799444,0.03287707992259514,"['RPS6', 'PRKCD']",0.9930684531677161,0,0,2
285,Cell cycle WP179,0.9281620183201529,0.44101318528799444,0.03287707992259514,"['TGFB1', 'ANAPC11']",0.9930684531677161,0,0,2
286,Regulation of Actin Cytoskeleton WP51,0.9281620183201529,0.44101318528799444,0.03287707992259514,"['TMSB4X', 'FGF1']",0.9930684531677161,0,0,2
287,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.936502507970191,0.3469387755102041,0.022760251924609735,['MAPK11'],0.9950339147183279,0,0,1
288,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.936502507970191,0.3469387755102041,0.022760251924609735,['TGFB1'],0.9950339147183279,0,0,1
289,Wnt signaling WP428,0.9550573901583234,0.30333333333333334,0.013948433256449207,['SFRP1'],0.9952509603141372,0,0,1
290,Development of ureteric collection system WP5053,0.9550573901583234,0.30333333333333334,0.013948433256449207,['GDF11'],0.9952509603141372,0,0,1
291,Hippo-Merlin Signaling Dysregulation WP4541,0.9550573901583234,0.30333333333333334,0.013948433256449207,['KIT'],0.9952509603141372,0,0,1
292,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9550573901583234,0.30333333333333334,0.013948433256449207,['SFRP1'],0.9952509603141372,0,0,1
293,Retinoblastoma gene in cancer WP2446,0.9550573901583234,0.30333333333333334,0.013948433256449207,['H2AFZ'],0.9952509603141372,0,0,1
294,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9681973927744398,0.26941798941798945,0.008707399300121361,['SFRP1'],0.9952509603141372,0,0,1
295,Circadian rhythm related genes WP3594,0.9696341518678835,0.3456924754634678,0.010659925848947253,"['CRH', 'RPS27A']",0.9952509603141372,0,0,2
296,Focal Adhesion WP306,0.9773657617199449,0.32239185750636135,0.00738094387178073,"['PDGFC', 'VEGFB']",0.9952509603141372,0,0,2
297,ESC Pluripotency Pathways WP3931,0.9775006036972822,0.2422857142857143,0.005513543246048027,['FGF1'],0.9952509603141372,0,0,1
298,Glioblastoma signaling pathways WP2261,0.9775006036972822,0.2422857142857143,0.005513543246048027,['PRKCD'],0.9952509603141372,0,0,1
299,Head and Neck Squamous Cell Carcinoma WP4674,0.9775006036972822,0.2422857142857143,0.005513543246048027,['RPS6'],0.9952509603141372,0,0,1
300,Ciliopathies WP4803,0.9840858227969886,0.22008658008658008,0.003530665769828274,['CCDC65'],0.9952509603141372,0,0,1
301,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9887460520767899,0.2015873015873016,0.002281515237093289,['SST'],0.9952509603141372,0,0,1
302,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9887460520767899,0.2015873015873016,0.002281515237093289,['TGFB1'],0.9952509603141372,0,0,1
303,Endochondral Ossification WP474,0.9887460520767899,0.2015873015873016,0.002281515237093289,['TGFB1'],0.9952509603141372,0,0,1
304,Ras signaling WP4223,0.9887460520767899,0.2015873015873016,0.002281515237093289,['KIT'],0.9952509603141372,0,0,1
305,"GPCRs, Class A Rhodopsin-like WP455",0.9931943371047098,0.2537163519485737,0.0017326104540291555,"['P2RY14', 'MCHR1']",0.996450711980463,0,0,2
306,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9980152721492765,0.14173669467787114,0.00028158829598999905,['TM7SF2'],0.9980152721492765,0,0,1
